Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Beta-cell transplantation in type 1 diabetic patients: a work in progress to cure.

Gillard P, Keymeulen B, Mathieu C.

Verh K Acad Geneeskd Belg. 2010;72(1-2):71-98.

PMID:
20726441
2.

Implantation of standardized beta-cell grafts in a liver segment of IDDM patients: graft and recipients characteristics in two cases of insulin-independence under maintenance immunosuppression for prior kidney graft.

Keymeulen B, Ling Z, Gorus FK, Delvaux G, Bouwens L, Grupping A, Hendrieckx C, Pipeleers-Marichal M, Van Schravendijk C, Salmela K, Pipeleers DG.

Diabetologia. 1998 Apr;41(4):452-9.

PMID:
9562350
3.

Comparison of sirolimus alone with sirolimus plus tacrolimus in type 1 diabetic recipients of cultured islet cell grafts.

Gillard P, Ling Z, Mathieu C, Crenier L, Lannoo M, Maes B, Roep B, Gorus F, Pipeleers D, Keymeulen B.

Transplantation. 2008 Jan 27;85(2):256-63. doi: 10.1097/TP.0b013e31815e8926.

PMID:
18212631
4.

Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus.

Warnock GL, Meloche RM, Thompson D, Shapiro RJ, Fung M, Ao Z, Ho S, He Z, Dai LJ, Young L, Blackburn L, Kozak S, Kim PT, Al-Adra D, Johnson JD, Liao YH, Elliott T, Verchere CB.

Arch Surg. 2005 Aug;140(8):735-44.

PMID:
16103282
5.

Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation center.

Goss JA, Schock AP, Brunicardi FC, Goodpastor SE, Garber AJ, Soltes G, Barth M, Froud T, Alejandro R, Ricordi C.

Transplantation. 2002 Dec 27;74(12):1761-6.

PMID:
12499894
6.

Long-term function (6 years) of islet allografts in type 1 diabetes.

Alejandro R, Lehmann R, Ricordi C, Kenyon NS, Angelico MC, Burke G, Esquenazi V, Nery J, Betancourt AE, Kong SS, Miller J, Mintz DH.

Diabetes. 1997 Dec;46(12):1983-9.

PMID:
9392484
7.

Restoring a functional beta-cell mass in diabetes.

Pipeleers D, Chintinne M, Denys B, Martens G, Keymeulen B, Gorus F.

Diabetes Obes Metab. 2008 Nov;10 Suppl 4:54-62. doi: 10.1111/j.1463-1326.2008.00941.x. Review.

PMID:
18834433
8.

Functional beta-cell mass and insulin sensitivity is decreased in insulin-independent pancreas-kidney recipients.

Gillard P, Vandemeulebroucke E, Keymeulen B, Pirenne J, Maes B, De Pauw P, Vanrenterghem Y, Pipeleers D, Mathieu C.

Transplantation. 2009 Feb 15;87(3):402-7. doi: 10.1097/TP.0b013e3181928a1c.

PMID:
19202446
9.

Correlation between beta cell mass and glycemic control in type 1 diabetic recipients of islet cell graft.

Keymeulen B, Gillard P, Mathieu C, Movahedi B, Maleux G, Delvaux G, Ysebaert D, Roep B, Vandemeulebroucke E, Marichal M, In 't Veld P, Bogdani M, Hendrieckx C, Gorus F, Ling Z, van Rood J, Pipeleers D.

Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17444-9. Epub 2006 Nov 7.

10.
12.

Reduction of blood glucose variability in type 1 diabetic patients treated by pancreatic islet transplantation: interest of continuous glucose monitoring.

Kessler L, Passemard R, Oberholzer J, Benhamou PY, Bucher P, Toso C, Meyer P, Penfornis A, Badet L, Wolf P, Colin C, Morel P, Pinget M; GRAGIL Group.

Diabetes Care. 2002 Dec;25(12):2256-62.

PMID:
12453970
13.

Metabolic characterization of long-term successful pancreas transplants in type I diabetes.

Robertson RP, Sutherland DE, Kendall DM, Teuscher AU, Gruessner RW, Gruessner A.

J Investig Med. 1996 Dec;44(9):549-55.

PMID:
9035608
14.

Beta-cell function and mass in type 2 diabetes.

Larsen MO.

Dan Med Bull. 2009 Aug;56(3):153-64.

PMID:
19728971
15.

Brittle type 1 diabetes mellitus.

Bertuzzi F, Verzaro R, Provenzano V, Ricordi C.

Curr Med Chem. 2007;14(16):1739-44. Review.

PMID:
17627511
16.

Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic beta-like cells.

Alipio Z, Liao W, Roemer EJ, Waner M, Fink LM, Ward DC, Ma Y.

Proc Natl Acad Sci U S A. 2010 Jul 27;107(30):13426-31. doi: 10.1073/pnas.1007884107. Epub 2010 Jul 7.

17.

A peptide-major histocompatibility complex II chimera favors survival of pancreatic beta-islets grafted in type 1 diabetic mice.

Casares S, Lin M, Zhang N, Teijaro JR, Stoica C, McEvoy R, Farber DL, Bona C, Brumeanu TD.

Transplantation. 2008 Jun 27;85(12):1717-25. doi: 10.1097/TP.0b013e31817752cc.

PMID:
18580462
18.

Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol.

Ryan EA, Lakey JR, Rajotte RV, Korbutt GS, Kin T, Imes S, Rabinovitch A, Elliott JF, Bigam D, Kneteman NM, Warnock GL, Larsen I, Shapiro AM.

Diabetes. 2001 Apr;50(4):710-9.

19.
20.

Improved metabolic control and quality of life in seven patients with type 1 diabetes following islet after kidney transplantation.

Cure P, Pileggi A, Froud T, Messinger S, Faradji RN, Baidal DA, Cardani R, Curry A, Poggioli R, Pugliese A, Betancourt A, Esquenazi V, Ciancio G, Selvaggi G, Burke GW 3rd, Ricordi C, Alejandro R.

Transplantation. 2008 Mar 27;85(6):801-12. doi: 10.1097/TP.0b013e318166a27b.

PMID:
18360260

Supplemental Content

Support Center